Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance

Jazz Pharmaceuticals (JAZZ) PT Lowered to $174 at RBC Capital

August 1, 2024 6:26 AM EDT

RBC Capital analyst Daniel Busb lowered the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $174.00 (from $175.00) while maintaining a Outperform rating.

The analyst comments "JAZZ puts up solid 2Q commercial numbers (avoiding a guide cut as recently feared), while the removal of Vision... More